Prostate Cancer

Researchers discover some tumors are more likely to be lethal than others

Most human cells have 23 pairs of chromosomes. Any deviation from this number can be fatal for cells, and several genetic disorders, such as Down syndrome, are caused by abnormal numbers of chromosomes. For decades, biologists have also known that cancer cells often have too few or too many copies of some chromosomes, a state known as aneuploidy. In a new study of prostate cancer, researchers have found that higher levels of aneuploidy lead to much greater lethality risk among patients. The findings suggest a possible way to more accurately predict patients' prognosis, and could be used to alert doctors which patients might need to be treated more aggressively, says Angelika Amon, the Kathleen and Curtis Marble Professor in Cancer Research in the Department [...]

2019-05-21T09:26:18-07:00May 21st, 2019|

When HIFU is the Right Treatment Option for Prostate Cancer

Is HIFU Prostate Cancer Treatment for You? Since many men are diagnosed with early-stage prostate cancer, often, they must choose between a risky surgical intervention, no treatment at all, or simply monitoring the disease. Among the many treatment options available HIFU falls somewhere in the middle. HIFU, which stands for high intensity focused ultrasound, offers a less invasive, lower risk method of eliminating the prostate in the body with fewer complications. With HIFU physicians are able to target and treat small amounts of tissue, minimizing damage to nerves around the prostate responsible for preserving potency. HIFU is an FDA approved precise and targeted therapy that reduces the risk of complications caused by surgery and radiation. HIFU uses ultrasound energy, or sound waves, to heat and [...]

2019-05-14T09:32:18-07:00May 14th, 2019|

HIFU for prostate cancer offers better outcomes for life

Using high energy ultrasound beams to destroy prostate cancer tumors shown to be as effective as surgery or radiotherapy, but with fewer side effects. A study, carried out at six hospitals across the UK, tracked 625 men with prostate cancer who received a type of treatment called high-intensity focused ultrasound (HIFU). The research is the largest ever study of HIFU treatment used to target prostate tumors. The treatment is similar to a 'lumpectomy' for other cancers -- where doctors remove only tumor cells, leaving as much healthy tissue as possible. The findings, from a number of institutions including Imperial College London and University College London, found that after five years the cancer survival rate from HIFU was 100 per cent. Approximately, 1 in 10 [...]

2019-04-16T09:01:00-07:00April 16th, 2019|

United States sees the biggest drop in prostate cancer rate

Prostate cancer incidence and mortality rates are decreasing or stabilizing in most parts of the world, with the United States recording the biggest drop in incidence, according to results presented at the AACR Annual Meeting 2019, March 29-April 3. Despite the trend toward declining or stabilizing rates, prostate cancer remains the second most commonly diagnosed cancer and the sixth leading cause of cancer death among men worldwide, said the study's lead author, MaryBeth Freeman, MPH, senior associate scientist, Surveillance Research, at the American Cancer Society in Atlanta. "Previous studies have indicated significant variation in prostate cancer rates, due to factors including detection practices, availability of treatment, and genetic factors," Freeman said. "By comparing rates from different countries, we can assess differences in detection practices [...]

2019-04-09T08:34:29-07:00April 9th, 2019|

Prostate cancer cells change the behavior of healthy cells

Prostate cancer cells change the behavior of other cells around them, including normal cells, by 'spitting out' a protein from their nucleus, new research has found. The tiny pieces of protein are taken up by the other cells, provoking changes that promote tumor growth and -- the researchers believe -- help the cancer hide from the body's immune system. The process has been captured for the first time on video (https://youtu.be/Ye4t9IJpRdo) by researchers at the University of Bradford and University of Surrey. The research is published today [26 March] in Scientific Reports. Lead researcher, Professor Richard Morgan from the University of Bradford, said: "For tumors to survive, grow bigger and spread they need to control the behavior of cancer cells and the normal cells [...]

2019-04-02T10:05:10-07:00April 2nd, 2019|

Empower Yourself With Prostate Cancer Facts

What are the symptoms of prostate cancer? Early prostate cancer usually causes no symptoms. Men who have prostate cancer can be symptom-free for years. But as it grows, prostate cancer can cause some symptoms. Men should see a health care provider if they: Have to urinate often, especially at night Have trouble starting or stopping urine flow Have a weak or slow urine flow Have blood in the urine or semen Feel frequent pain or stiffness in the lower back, hips, or ribs Conditions other than prostate cancer could cause these symptoms. But the only way to know what’s causing them is to see a health care provider. HIFU Prostate Cancer Facts What do you need to know about the American Cancer Society® prostate [...]

2019-03-26T12:17:00-07:00March 26th, 2019|

Compounds in coffee may inhibit the growth of prostate cancer

For the first time, scientists have identified compounds found in coffee which may inhibit the growth of prostate cancer. This is a pilot study, carried out on drug-resistant cancer cells in cell culture and in a mouse model; it has not yet been tested in humans. This work is presented at the European Association of Urology congress in Barcelona, after publication in the peer-reviewed journal The Prostate. Coffee is a complex mixture of compounds which has been shown to influence human health in both positive and negative ways. There is increasing evidence that drinking certain types of coffee is associated with a reduction in incidence of some cancers, including prostate cancers. Now Japanese scientists have studied the effects of two compounds found in coffee, [...]

2019-03-19T08:36:47-07:00March 19th, 2019|

No obvious benefits for prostate cancer patients using low-dose aspirin

Low-dose aspirin use does not seem to reduce the overall risk for prostate cancer death at the population level. However, results for extended exposure periods suggest that low-dose aspirin might be inversely associated with prostate cancer mortality after 5 years from cancer diagnosis. Findings from a nationwide cohort study are published in Annals of Internal Medicine. Recent studies suggest that aspirin use may improve survival in patients with prostate cancer, but study results are inconclusive. Researchers from the Danish Cancer Society Research Center, Aarhus University Hospital, Copenhagen University Hospital, and University of Southern Denmark used nationwide registries in Denmark to assess the association between postdiagnosis use of low-dose aspirin and prostate cancer mortality. Their analysis did not find convincing evidence of an overall protective [...]

2019-03-05T11:54:54-07:00March 5th, 2019|

HIFU Patients Urged to Advocate for Reimbursements

Advocating for HIFU Reimbursement Men who may have benefited from HIFU for Prostate Cancer are being asked to help more men receive this life-saving procedure. HIFU Prostate Services and California HIFU is asking past-patients to help newly diagnosed men have a greater opportunity to receive HIFU for prostate cancer by advocating for higher Medicare reimbursement for HIFU. The steps have been outlined below to help with this process, along with tips for being as effective as possible. Finding Your Representatives Click here to search the House of Representatives Click here to search for your Senators Write a Letter to Your Representatives in Congress Now that you have found your representatives in Congress and the Senate, one of the easiest ways to help is to [...]

2019-02-26T08:19:47-07:00February 26th, 2019|

Active surveillance nearly tripled in men with low-risk prostate disease

Many men with low-risk prostate cancer who most likely previously would have undergone immediate surgery or radiation are now adopting a more conservative "active surveillance" strategy, according to an analysis of a new federal database by scientists from Dana-Farber Cancer Institute. The use of active surveillance increased from 14.5 percent to 42.1 percent of men with low-risk prostate cancer between 2010 and 2015, said the researchers, led by Brandon Mahal, MD, from the department of radiation oncology at Dana-Farber/Brigham and Women's Cancer Center who led the study published by JAMA. During that same period, the percentage of men undergoing radical prostatectomy (removal of the prostate gland) declined from 47.4 percent to 31.3 percent. The use of radiotherapy for low-risk disease dropped from 38.0 percent [...]

2019-02-12T11:42:12-07:00February 12th, 2019|